PMID: 42211692

DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.

Sasset Linda, Cameron Andrew D, Sussman Carleigh, Rubinelli Luisa, Maji Debnath, Miller Robert, Thompson Andy, Campbell Delcora, Walker Melanie R, Drozdz Marek M

Molecular therapy. Nucleic acids · 2026

Vol. 37, Issue 2, pp. 102946

This entry links to third-party literature. For research use only.